Financial statements review January—December 2025 presentation

‌Q4 Financial statements review

January-December 2025

President and CEO Hannu Martola | 5 February 2026

2 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Q4: A stable year-end, outlook strengthened

Sales in medical developed well but declined in security; total net sales were flat at comparable rates

Industrial sales -7%

• Decline in line-scan sales, but significant growth in TFT flat panel detectors for battery inspection in APAC

• Growth in other regions supported by food scanning

  Medical sales +19%

  • Growth driven by CT applications, particularly in China

    Security sales -29%

  • Sales declined across all main markets

  • One-off-events in EMEIA, strong comparison period, the after-effects of the aviation 100 ml regulation, OEMs' inventory buffer, and a temporary standstill in demand in India

  • In APAC, demand remained subdued

50%

growth in TFT sales

3 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Net sales by quarter

(EUR 1,000)

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2022 2023 2024 2025

35,000

30,000

25,000

20,000

15,000

-6.1

(YOY change-%)

10,000

5,000

0

4 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Operating margin (EBITA) excluding NRI

(EUR 1,000)

14.8%

15.3%

12.7%

12.4%

11.4%

10.0%

7.4%

6.3%

5.2%

2.3%

7.0%

5.4%

6.5%

9.0%

9.9%

6,000 25%

5,000

20%

4,000

3,000

2,000

15%

10%

5%

1,000

Q122

Q222

Q322

Q422

Q123

Q223

Q323

Q423

Q124

Q224

Q324

Q424

Q125

Q225

Q325

Q425

0 0%

EBITA excluding NRI (EUR 1,000) EBITA-% excluding NRI Mid-term EBITA-target 15%

5 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Q4 2025 sales split by regional business units

7.2%

26.7%

29.7

€m

TOTAL NET SALES

66.1%

6 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Q4 2025 sales split by main applications

16.3%

33.6%

29.7

€m

TOTAL NET SALES

50.2%

7 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

8 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌FY 2025 sales split by regional business units

5.1%

25.2%

101.0

€m

TOTAL NET SALES

69.7%

9 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌FY 2025 sales split by main applications

18.4%

35.4%

101.0

€m

TOTAL NET SALES

46.2%

10 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Key figures

11 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Target 2026-2030

We outgrow the market by driving customer success with smart, data-generating X-ray detectors and outstanding usability.

12 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌14%

4%

By application

13%

69%

Medical

DIGITAL

X-RAY DETECTOR MARKET 2030

3.0

€ bn

Ageing population Security Concerns

34%

By technology

4% 5%

15%

Flat panel TFT

42%

Veterinary

Industrial

Security

Quality and efficiency Eco and circular economies

Lack of raw materials Digitalization and AI

Flat panel CMOS

Line scan and CT

Photon counting

Others

13 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Strategic levers

BASE

Continue to do what we do, better

TFT

Drive TFT flat panel growth, across regions and markets

ADDED VALUE

Commercialize more value-added integrated HW-SW solutions to a broader customer base

NEW TECH

Seek new opportunities beyond current scope (Photon counting & SW)

Being the most trusted partner that drives customer success through exceptional usability

Elevate performance culture

14 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

Opening of the India factory and start of customer deliveries

‌Strategy implementation and main events in Q4

Improved data management for PCCT

AVA

Advanced. Versatile. Affordable.

40% less materials, up to 50% cost savings without compromising imaging performance

for security and industrial line-scans

15 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Sales expectation Q1 and H1 2026

Industrial

to grow in Q1

Medical

to grow in Q1

Security

to grow in Q1

Q1 sales are expected to grow in all regions: APAC, EMEIA, and the Americas

YOY total net sales to grow by a double-digit rate in Q1 and H1 2026

16 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌Business outlook

Detection Technology expects double-digit year-on-year net sales growth in Q1 and H1 of 2026.

The geopolitical situation, new U.S. import tariffs, U.S. relations with other countries, and price competition especially in China create uncertainty.

17 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌EPS and payout

(EUR)

1.20

1.00

0.30 € dividend (0.50)

0.80

0.60

0.40

68% payout (66%)

The Board's proposal to the AGM 2026

0.20

0.00

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Earnings per share Dividend or capital repayment

The company aims to distribute approximately 30-60% of the Group's annual result (earnings per share) to shareholders as dividends.

18 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

‌FINANCIAL TARGETS

19 5.2.2026 Detection Technology | Financial statements review January-December 2025 presentation

https://www.deetee.com